MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 262 filers reported holding MYRIAD GENETICS INC in Q2 2013. The put-call ratio across all filers is 3.97 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $413,000 | -30.6% | 14,967 | -18.8% | 0.06% | -34.8% |
| Q3 2021 | $595,000 | -48.5% | 18,423 | -51.2% | 0.09% | -48.6% |
| Q2 2021 | $1,155,000 | -13.0% | 37,762 | -13.4% | 0.18% | -17.1% |
| Q1 2021 | $1,327,000 | -79.7% | 43,591 | -86.8% | 0.22% | -81.6% |
| Q4 2020 | $6,547,000 | +46.7% | 331,098 | -3.3% | 1.18% | +15.3% |
| Q3 2020 | $4,463,000 | +24.6% | 342,259 | +8.4% | 1.02% | +25.0% |
| Q2 2020 | $3,582,000 | -21.3% | 315,835 | -0.7% | 0.82% | -34.9% |
| Q1 2020 | $4,552,000 | -50.3% | 318,127 | -5.3% | 1.25% | -33.1% |
| Q4 2019 | $9,150,000 | -4.0% | 335,991 | +2.3% | 1.88% | -9.0% |
| Q3 2019 | $9,533,000 | +105.8% | 328,343 | +96.9% | 2.06% | +103.1% |
| Q2 2019 | $4,633,000 | -6.9% | 166,772 | +11.3% | 1.02% | -9.4% |
| Q1 2019 | $4,974,000 | +13.9% | 149,798 | -0.3% | 1.12% | +10.6% |
| Q4 2018 | $4,367,000 | -42.5% | 150,219 | -9.0% | 1.01% | -28.6% |
| Q3 2018 | $7,594,000 | -37.0% | 165,071 | -48.9% | 1.42% | -37.9% |
| Q2 2018 | $12,062,000 | +5.4% | 322,780 | -16.6% | 2.28% | +12.0% |
| Q1 2018 | $11,439,000 | -30.1% | 387,084 | -18.7% | 2.04% | -26.5% |
| Q4 2017 | $16,354,000 | -7.3% | 476,156 | -2.3% | 2.77% | -12.0% |
| Q3 2017 | $17,637,000 | +33.2% | 487,501 | -4.9% | 3.15% | +30.8% |
| Q2 2017 | $13,245,000 | +32.7% | 512,581 | -1.4% | 2.41% | +27.0% |
| Q1 2017 | $9,980,000 | +22.3% | 519,807 | +6.2% | 1.90% | +44.8% |
| Q4 2016 | $8,159,000 | -38.5% | 489,410 | -24.1% | 1.31% | -40.6% |
| Q3 2016 | $13,270,000 | +29.0% | 644,837 | +91.9% | 2.20% | +31.0% |
| Q2 2016 | $10,283,000 | -17.6% | 336,048 | +0.8% | 1.68% | -19.0% |
| Q1 2016 | $12,472,000 | -12.9% | 333,216 | +0.4% | 2.08% | -6.5% |
| Q4 2015 | $14,324,000 | -5.0% | 331,885 | -17.5% | 2.22% | -4.3% |
| Q3 2015 | $15,076,000 | +9.9% | 402,258 | -0.3% | 2.32% | +15.7% |
| Q2 2015 | $13,718,000 | -1.5% | 403,609 | +2.6% | 2.01% | -3.8% |
| Q1 2015 | $13,928,000 | +7.7% | 393,446 | +3.6% | 2.08% | +11.0% |
| Q4 2014 | $12,934,000 | -4.2% | 379,724 | +8.5% | 1.88% | -6.9% |
| Q3 2014 | $13,500,000 | -0.4% | 350,002 | +0.5% | 2.02% | -1.2% |
| Q2 2014 | $13,559,000 | -17.0% | 348,386 | -27.1% | 2.04% | -12.2% |
| Q1 2014 | $16,333,000 | +56.4% | 477,707 | -4.0% | 2.32% | +56.6% |
| Q4 2013 | $10,442,000 | +11.5% | 497,703 | +24.9% | 1.48% | +1.9% |
| Q3 2013 | $9,367,000 | -17.1% | 398,578 | -5.2% | 1.46% | -26.4% |
| Q2 2013 | $11,302,000 | – | 420,601 | – | 1.98% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 5,000,000 | $90,850,000 | 3.94% |
| Altium Capital Management LP | 221,000 | $4,016,000 | 1.61% |
| DISCIPLINED GROWTH INVESTORS INC /MN | 1,900,787 | $34,537,000 | 0.93% |
| Zebra Capital Management LLC | 15,352 | $279,000 | 0.82% |
| PFM Health Sciences, LP | 1,177,250 | $21,391,000 | 0.82% |
| EARNEST PARTNERS LLC | 6,462,138 | $117,417,000 | 0.78% |
| Glenview Capital Management | 1,696,791 | $30,831,000 | 0.77% |
| AIMZ Investment Advisors, LLC | 42,085 | $765,000 | 0.37% |
| Phocas Financial Corp. | 127,949 | $2,325,000 | 0.35% |
| Redhawk Wealth Advisors, Inc. | 34,680 | $630,000 | 0.29% |